Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »
Reset 

Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  Biohaven Pharmaceutical Holding Company Ltd.

HealthLynked to Premier 'Forever: The End of Aging' Medical Documentary at CMX CinéBistro Theater in Naples, Florida on August 28th

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  Insmed Incorporated

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  Meridian Bioscience, Inc.

NIH's All of Us Research Program Continues Nationwide Journey Tour After Two-Year Pandemic Pause; Enrolling New Participants for Historic Biomedical Database in Colorado (8/9-9/2)

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

Pharma Plant Machinery and Equipment Sourcing and Procurement Report | Forecast and Analysis 2022-2026| SpendEdge

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

Relmada Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11, 2022

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  Relmada Therapeutics, Inc.

Results of a Multicenter Study on Delcath's CHEMOSAT® Hepatic Delivery System Published in Cardiovascular and Interventional Radiology

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  Delcath Systems, Inc.

CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  CASI Pharmaceuticals, Inc.

PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  Pacific Biosciences of California, Inc.

Inpatient Rehabilitation Post Open-Heart Surgery Helps Patients Return to Daily Life Activities - Faster and Safer

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

Regenics Introduces an Updated, Preventative and Regenerative approach to Health

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

Rod Burkett, of Gardant Management Solutions, Named a Pioneer in Senior Living

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

Hospital PMI® at 54.9%; July 2022 Hospital ISM® Report On Business®

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

California Northstate University College of Pharmacy Ranked #6 Among all Pharmacy Schools in California

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

Vaccines Market to grow at a CAGR of 4.13% by 2026, Evolving Opportunities with Johnson and Johnson & Bharat Biotech Ltd - Technavio

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

FDA Infant Formula Update: August 5, 2022

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  U.S. Food and Drug Administration

FDA Approves First Targeted Therapy for HER2-Low Breast Cancer

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
Related companies:  U.S. Food and Drug Administration

Mid-Size Pharmaceutical Market to Reach $100.05 Billion by 2028

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022

TIM3 Inhibitors Drug Clinical Trials Research Report 2022: Insight on Emerging TIM3 Inhibitors in Development As Monotherapy & Combination Therapy

Read more ››
By: PR Newswire Association LLC. - 05 Aug 2022
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »
to the top ↑